The future of BRD9 inhibitors: a patent perspective (2019-present)
{{output}}
Introduction: Bromodomain-containing protein 9 (BRD9) is an epigenetic reader component of the non-canonical BAF (BRG1/BRM-Associated Factors) chromatin remodeling complex, involved in the regulation of transcription. The ncBAF c... ...
